Cargando…
Preliminary Results of the First 50 Patients Undergoing Sclerotherapy for II-Degree Hemorrhoidal Disease Using an Automated Device
BACKGROUND: Sclerotherapy is defined as the injection of sclerosant agents causing fibrosis and scarring of the surrounding tissue. It is currently employed for the treatment of I-III degree hemorrhoidal disease (HD). The aim of this study is to investigate the use of a new automated device for the...
Autores principales: | Goglia, Marta, Nigro, Casimiro, Aurello, Paolo, Diaco, Elia, Trompetto, Mario, Gallo, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046905/ https://www.ncbi.nlm.nih.gov/pubmed/35495738 http://dx.doi.org/10.3389/fsurg.2022.882030 |
Ejemplares similares
-
Sclerotherapy for III- and IV-degree hemorrhoids: Results of a prospective study
por: Lisi, Giorgio, et al.
Publicado: (2022) -
Sclerotherapy in Hemorrhoids
por: He, Anling, et al.
Publicado: (2022) -
The impact of intraoperative “Nerve Monitoring” in a tertiary referral center for thyroid and parathyroid surgery
por: Princi, Pietro, et al.
Publicado: (2022) -
Sclerobanding in the treatment of second and third degree hemorrhoidal disease in high risk patients on antiplatelet/anticoagulant therapy without suspension: a pilot study
por: Pata, Francesco, et al.
Publicado: (2023) -
Management and Treatment of External Hemorrhoidal Thrombosis
por: Picciariello, Arcangelo, et al.
Publicado: (2022)